Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Aldeyra Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 111 | 2 | 95 | −14 |
| Shares | 38.6M | 132.2K | 37.0M | −1.56M (−4.0%) |
| Value | $171.8M | $588.0K | $147.5M | −$23.8M (−13.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 971,781 | $3.88M | 0.16% |
| Renaissance Technologies LLC | 514,100 | $2.05M | 0.00% |
| Ergoteles LLC | 238,500 | $952.0K | 0.03% |
| Jacobs Levy Equity Management, Inc | 234,670 | $936.0K | 0.01% |
| Bank of Montreal | 80,700 | $324.0K | 0.00% |
| Marshall Wace, LLP | 77,681 | $309.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 67,914 | $271.0K | 0.00% |
| Caxton Associates LP | 57,860 | $231.0K | 0.03% |
| Private Advisor Group, LLC | 49,165 | $196.0K | 0.00% |
| Graham Capital Management, L.P. | 42,385 | $169.0K | 0.01% |
| Thrivent Financial for Lutherans | 41,113 | $164.0K | 0.00% |
| AQR Capital Management LLC | 40,954 | $163.0K | 0.00% |
| XTX Topco Ltd | 21,841 | $87.0K | 0.04% |
| Qube Research & Technologies Ltd | 19,415 | $77.0K | 0.00% |
| LMR Partners LLP | 17,311 | $69.0K | 0.00% |
| PEAK6 Investments LLC | 5,500 | $46.1K | 0.00% |
| Wolverine Trading, LLC | 10,309 | $41.0K | 0.00% |
| Quantbot Technologies LP | 4,668 | $18.0K | 0.00% |
| Cutler Group LP | 1,596 | $6.00K | 0.00% |
| Truvestments Capital LLC | 929 | $4.00K | 0.00% |
| Steward Partners Investment Advisory, LLC | 600 | $2.00K | 0.00% |
| Credit Suisse AG | 26 | $0 | 0.00% |
Sold out (36)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 124,299 | $553.0K |
| Amalgamated Financial Corp. | 7,928 | $35.0K |